Background. Despite progress in diagnostic procedures, clinical diagnosis is not always confirmed by an autopsy. An autopsy is a valuable tool in evaluating diagnostic accuracy.
Introduction
In the past few decades, great progress has been made in the management of hematological malignancies. However, the mortality rates in these diseases are still high and the immediate causes of death are not always clear when only clinical data is taken into consideration. It is essential to elucidate the precise causes of mortality in hematological malignancies and aplastic anemia in order to properly focus the research efforts and to improve the management and treatment.
Previous studies in different medical specialties have shown that clinical diagnoses of causes of death are characterized by a high discordance rate (0-29%) with autopsy findings. [1] [2] [3] [4] [5] [6] It could be even higher in specific groups with particularly severe or rare diseases, e.g., in cancer patients. 1, 7, 8 This suggests the post-mortem examination to be the best tool to verify the clinical diagnosis. [9] [10] [11] [12] In this study, we have compared clinically made diagnoses of immediate causes of death with autopsy findings in 154 patients with hematological malignancies or aplastic anemia. We intended to identify the most probable causes of death in different hematological diseases, the most frequently missed diagnoses and the discordance rate between clinical and anatomopathological investigation.
Material and methods

Patients
The study was performed in the Department of Hematology, Oncology and Internal Diseases at Medical University of Warsaw, Poland. After reviewing the reports of 1,179 cases of patients who died in the years [1993] [1994] [1995] [1996] [1997] [1998] [1999] [2000] [2001] [2002] [2003] [2004] in this Department, it was found that 181 autopsies (15.6%) were performed, and from that group 27 cases (14.9%) were excluded because of incomplete records of either the clinical course of disease (2 cases), autopsy (23 cases) or both (2 cases). The remaining 154 cases (13.1% of all deaths) composed the study population, which was characterized by a median age of 50.9 years (±17.1), even sex distribution -77 males (50%) and 77 females (50%), and clinical diagnosis and the stage of the disease as shown in Table 1 .
The distribution of primary hematological diseases in the entire reviewed group of 1,179 cases is displayed in Table 1 , together with the distribution of diagnoses in patients who underwent an autopsy examination.
Autopsy
Patients were selected for the autopsy in this Department on the basis of relatively uniform criteria, defined as follows:
• any death within 24 h of admission;
• death unexplained by the clinical situation of the patient, including sudden death;
• death while participating in a clinical trial;
• death after any form of hematopoietic stem cell transplantation. For the purpose of this study, patients were categorized into early or advanced primary disease at the time of death. Early disease, for the purpose of this study, is the disease that should not be by itself an immediate cause of death and involves a patient who still has available treatment options. Advanced disease, for the purpose of this study, is the endstage, progressive disease, not responding to treatment, which is most likely the immediate cause of death or results in such a deterioration of performance status that could make a patient vulnerable to any secondary cause of death.
In Poland, the law requires an autopsy for all patients who have died in hospital, but when there is no doubt regarding the cause of death, the Chief of the Department can evade this requirement upon written request from the patient's family. Routinely, autopsies are bypassed in the case of almost all patients with advanced diseases. Bypassing an autopsy is not permitted in the case of patients dying within 24 h of admission as it is legally assumed that the hospital did not have enough time to precisely identify the clinical problems of the patient. An autopsy is performed not earlier than 12 h after death, and in this hospital it is done usually on the next day, except for patients dying on a Friday and Saturday. Their autopsies are performed on a Monday.
A complete autopsy includes a gross examination of the viscera of the cranium, thorax, abdomen and pelvis, and a collection of tissue specimens that are used for subsequent microscopic evaluations, including special immunohistochemistry staining if necessary. Moreover, special attention to the requests of clinicians is given, who may suggest a collection of a larger than routine number of specimens for microscopic analysis from selected locations.
Data analyzed
The medical documentation was analyzed with attention to the patient's sex, age, hematological diagnosis and its prognosis, treatment given, time from diagnosis, length of the last hospitalization, comorbidities, suggested cause of death, presence of the Aspergillus spp. infection.
In each case, all the clinical data and autopsy records were evaluated by at least 2 physicians. All doubtful autopsy cases were reviewed by a pathologist other than the one who performed a given autopsy.
The patients were assigned to 3 age groups (18-42; 43-62; >62 years). Specific treatment for the disorders of the last period of life, chemotherapy, radiotherapy and bone marrow or peripheral blood stem cell transplantation were also taken into consideration. Time from diagnosis meant the time from precise diagnosis of hematological disease until death. The mode of dying was an indication whether the process of dying was rapid (hemorrhage, myocardial infarction, arrhythmia, pulmonary embolism or septic shock) or prolonged (others). Special attention was given to the Aspergillus spp. infection because of its known high incidence in hematological patients.
13
Discordance evaluation
The most probable immediate cause of death was defined on the basis of an autopsy study and compared with clinical diagnosis. As a result, the clinically suspected cause of death was classified as concordant or discordant with autopsy findings and categorized according to Goldman's criteria (Table 2) . 5 An experienced clinical hematologist reviewed the doubtful cases. Minor misdiagnoses, not contributing to the immediate cause of death, were not considered. The group of 5 patients whose immediate cause of death was not identified even after an autopsy was excluded from further analysis.
The association between the presence of major class discrepancies and the clinical characteristics of the patients was evaluated. The characteristics comprised of the following factors: age (18-42 years; 43-62 years; >62 years), time from the diagnosis of primary hematological disease (<1 month; >1 month), stage of primary disease (advanced or early), duration of the last hospitalization (<8 days; 8-30 days; >30 days), mode of dying (rapid, prolonged), treatment with bone marrow transplantation (BMT) or peripheral blood stem cell transplantation (PBSCT), and presence of the Aspergillus spp. infection.
Statistical analysis
The data was processed using statistical analysis system (SAS) and Microsoft Excel software. Simple proportions were reported with their 95% confidence intervals (95% CI). The association between the clinical characteristics and discrepancy rates was analyzed using the χ 2 test. A p-value of 0.05 or less was considered to indicate statistical significance.
Results
The entire group of 154 autopsies consisted of 11 (7.1%) autopsies performed because patients died within 24 h of admission, 142 (92.2%) autopsies performed because of sudden or unexplained death, 8 (5.2%) autopsies performed on patients participating in clinical trials, and 22 (14.3%) autopsies performed on patients dying after earlier hematopoietic transplantation. Twenty-six (16.9%) autopsies were performed because of more than 1 reason.
The median time from the diagnosis of primary hematological disease to death was 494 days. Seventy-seven patients (50.0%; 95% CI 41.9-58.2%) died in advanced stages of their diseases. The median length of the last hospitalization was 26.5 days (±34.9). The mode of dying was rapid in 95 patients (61.7%; 95% CI 53.5-69.4 %) and did not 
Immediate causes of death
Clinical diagnoses of death of patients who were forwarded for autopsy evaluation are listed in Table 3 . The most frequent diagnoses of the immediate causes of death as determined by the autopsies of the evaluated patients are shown in Table 4 . As it can be observed, the most frequent autopsy-identified cause of death was myocardial infarction. In almost each hematological malignancy, myocardial infarction (ischemia) was the most frequent pathological diagnosis of the immediate cause of death (Table 5) . Also considering the age groups, myocardial infarction appeared to be the most common cause of death, characterized by a frequency rate increasing with age (Table 6 ).
With regard to the patients with early stages of primary diseases, the most frequent immediate causes of death were myocardial infarction (15; 19.5%), bacterial pneumonia 9 (11.7%), and pulmonary embolism (7; 9.1%).
Considering the etiology, post-mortem diagnoses of the immediate causes of death were assigned to 9 categories (Table 7) . In 5 patients (3.2%; 95% CI 0.4-5.6%), the exact cause of death was not identified, even after an autopsy.
The most frequent immediate cause of death in 22 patients with prior bone marrow or peripheral blood stem cell transplantation was aspergillosis (27.3%), mainly in the pulmonary location (4 out of 6 patients).
Discordances between clinical and anatomopathological investigation
The discordance between clinical and autopsy diagnoses of the immediate cause of death was found in 55 patients (35.7%; 95% CI 28.2-42.8%). The discrepancies were considered class I in 28 cases (18.2%) and class II in 27 cases (17.5%). The details of the discordant cases (class I) are displayed in Table 8 . Myocardial infarction was the most frequent class I discrepant diagnosis (42.9%). Pulmonary aspergillosis, myocardial infarction and gastrointestinal bleeding were the most frequently clinically undiagnosed causes of death (Fig. 1) . A more precise analysis of patients with myocardial infarction showed that 6 of them (20.7%) had a previously diagnosed cardiac disease. The remaining 23 patients with myocardial infarction had a 65.2% discrepancy rate. The major discrepancy in the diagnosis of myocardial infarction regarded patients in whom There were no significant differences in the discrepancy rate between patients with different primary hematological diseases ( Table 1) .
The discrepancy rate in patients with the Aspergillus spp. infection was 42.1%; however, in the group with the pulmonary location, it was 71.4%.
No significant association was found between a major class discordant diagnosis and age, diagnosis time and prognosis of hematological disease, duration of the last hospitalization, mode of dying, prior transplantations (BMT or PBSCT), presence of the Aspergillus spp. infection ( Table 9 ).
Discussion
To the authors' best knowledge, this study concerns the largest series of autopsies of patients with hematological malignancies and aplastic anemia, and the only one that is focused on an actual, immediate cause of death.
The analysis concerned a group of patients with a fully diagnosed hematological disease. All of them were diagnosed, examined and treated in a highly specialized hematological unit, which assures the uniformity of patient care and decreases the risk of misdiagnosis. 1, 14 The study regarded only the patients with the postmortem examination because it seems to be the best tool to verify clinical diagnosis. However, the 15.6% autopsy rate and the limitation to the preselected group of patients may result in the lack of representativeness for the entire population of hematological patients and can lead to an overestimation of discrepancies. On the other hand, the clinical characteristics of the patients including age, sex, underlying hematological disease and its prognosis, length of patient care, length of the last hospitalization, suggest that the studied population was very diverse. The differences in the autopsy rate between primary hematological diseases probably result from an acute course of leukemia with a high frequency of death unexplained by the clinical situation of a patient.
The post-mortem study allowed us to identify the immediate cause of death in 96.8% of cases. Only close collaboration of pathologists and clinicians can make an autopsy study such an effective tool in defining the immediate cause of death. 7, 14, 17 Various combined infections were the most frequent causes of death (26.6% of cases), especially in younger patients (<43 years; 36.5%). Such data is in accordance with the studies conducted by Goldman et 5, 7, 8, 17, 18 A more detailed analysis of infectious causes of death revealed that bacterial pneumonia, pulmonary aspergillosis and septic shock were the most frequent causes. Additionally, it was found that 24 out of 41 infectious cases (58.5%) involved the respiratory tract.
The most frequent cause of death, when considering single pathology, was myocardial infarction (18.8% of cases). Furthermore, myocardial infarction was observed to be the most frequent immediate cause of death in all age groups (<43 years; 43-62 years; >62 years) and almost in each hematological malignancy. There are many factors that predispose hematological patients to heart failure: age, anemia, cardiotoxicity of chemotherapeutics, overload with fluids, increased body temperature, to name a few. Moreover, some symptoms of cardiac insufficiency may be masked by therapy or other complications, e.g., pain, tachypnea. The major discrepancy in the diagnosis of myocardial infarct considered CNS bleedings. The discrepancy is probably due to the unspecific symptoms that mask heart failure, and the diagnosis of CNS hemorrhage seems to be a safe guess for the doctor. The majority of patients who died of myocardial infarction (22/29; 75.9%) were exposed to chemotherapeutic agents of known cardiotoxicity, usually anthracyclines or radiotherapy. 12, [19] [20] [21] [22] 23 To the authors' best knowledge, this is the first study reporting myocardial infarction as the most frequent cause of death.
The underlying hematological disease was found to be the immediate cause of death in 10 patients (6.5%). Such an observation differs from that reported by Provencio et al. in patients with Hodgkin's lymphoma (37%), but is similar to the observation of Gerrain et al. in cancer patients (11.8%). 7, 8 The discordance rate between clinical and post-mortem diagnoses of the immediate cause of death was 35.7%. This may seem high, but an autopsy was ordered primarily in cases where clinical diagnosis was doubtful or the cause of death was at least partially unexplained to the ordering physician. Previously conducted studies in hematological and oncological units showed a higher incidence of discrepancies. 7, 8 A systematic review performed by Shojania et al., who evaluated 53 studies of autopsy series concerning patients with various disorders, other than hematological, revealed a range of major errors from 4.1% to 49.8%.
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Our data is within these limits.
In this study, management would have been modified (class I discrepancies) in 18.2% of cases. It is apparently more frequently than in other studies of patients without neoplasia but less frequently than in the studies of oncological patients. 1, 5, 7, 11, 23, 24 A higher rate of class I discrepancies reported by Xavier et al. in hematological patients (31.3%) may be due to the treatment in an unspecialized unit. 14 All the data might confirm that a highly complex course of malignant disorders might result from the elevated rates of discrepancies. The evaluation of the prognosis was performed in order to assess if the modification of management in class-I-discrepant patients could have influenced the survival. It was shown that 39.3% of class-I-discrepant patients were in the early stages of their primary diseases. This may suggest that an appropriate modification of management focused on early diagnosis and treatment of heart infarct may decrease the mortality rate.
An unexpected and previously not reported observation was that myocardial infarct or extensive myocardial ischemia was undiagnosed in 69% of cases. The clinically suspected causes of death in these patients were hemorrhages, especially cerebral, septic shock and disseminated hematological disease. This suggests more intensive attention to the cardiac problems in hematological patients.
Infection was misdiagnosed in 18 out of 41 cases (43.9%). This finding is in accordance with various studies. 5, 7, 16, 25, 26 However, the number of undiagnosed infections in some studies is higher. 18, 27 A more detailed analysis showed that 42.1% of the Aspergillus spp. infections and 71.4% of pulmonary aspergillosis were overlooked. Donhuijsen et al. reported a high and increasing incidence of mycoses in hematological patients, which positively correlates with the present study. 13 As previously suggested by other authors, infectious processes are likely to remain undetected and their symptoms can mimic tumor progression.
Pulmonary embolism was observed as the most frequent missed diagnosis in various studies. 7, 25, 28 This was not confirmed by our study (33.3% of discrepant cases). The difference may result from the limitation of our group to hematological patients and previously reported decreasing incidence of misdiagnosed pulmonary embolism. 5 Xavier et al. reported hematological disease to be the most commonly discordant diagnosis in hematological patients. 14 The present study was performed in a specialized hematological unit, which probably limited the rate of misdiagnoses. Another purpose of this study was to assess the occurrence of discrepancies in accordance with clinical characteristics. No clinical feature showed a statistically significant relation to major or class I discrepancies. Underrepresented studies regarding the association of a clinical characteristic with major class discrepancies reported various data, of which only care in a specialized unit was independently and inversely related to the occurrence of class I discrepancy. 2, 14, 29, 30 In the present study, all the patients were hospitalized in a specialized unit, which excludes the possibility of such a relation.
The underlying hematological disease by itself rarely leads to death, while the complications of therapy and specific disorders appearing in its course in the majority of cases are responsible for the patient's death. An autopsy study together with a clinical investigation providing the information about the immediate cause of death focus the attention of clinical physicians on frequently misdiagnosed, life-threatening pathologies. It seems essential to perform comprehensive analyses of the results of post-mortem examinations to make the autopsy findings available to a wider group of physicians in charge of the patients, which might result in a decrease of discrepancies in the future.
Conclusions
This data suggests that hematological patients require special attention and preventive measures concerning coronary heart disease, particularly during the initiation of antineoplastic therapy.
